News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
en
CPHI meetings are now available with our solid-state and formulation experts, providing you with line of sight to FIH. Our leadership team will be helping drug innovators map their full CMC drug development from lead optimization to market formulation.
Schedule a discussion from April 25-27 at https://lnkd.in/etEcg-tn
Food, drinks, and accelerated development. Join us on this Tuesday at CPHI for a happy hour conversation.
Stop by Booth 841 on 4/25 from 1:30pm-4:30pm or schedule a meeting for another time: https://lnkd.in/etEcg-tn
Ready for an evening of unscripted connection?
Please complete the form to register for our San Diego Biotech and Pharma R&D social. Note: Registration is subject to review. You will receive a formal confirmation email once your attendance is approved.
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your registration. The information you submit will be governed by our Privacy Policy.
_.webp "A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs")
Subscribe to be the first to get the updates!
